NCT05997056
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05997056
Title Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aadi Bioscience, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 United States Details
Rocky Mountain Cancer Centers Denver Colorado 80218 United States Details
Texas Oncology Dallas Texas 75246 United States Details
Medical College of Wisconsin Cancer Center Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field